Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

NCT: NCT07499258 · NOT_YET_RECRUITING

NCT IDNCT07499258
StatusNOT_YET_RECRUITING
Start Date2026-06
Completion2029-12

Brief Summary

Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.

Frequently Asked Questions

What is Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence?

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence is a clinical trial registered under NCT07499258. Current status: NOT_YET_RECRUITING.

What is the status of NCT07499258?

The current status of NCT07499258 (Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence) is: NOT_YET_RECRUITING.

When did Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence start?

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence started on 2026-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑